News and press mentions
Latest news
Startup hyrede ham efter 18 år i Novo Nordisk: Nu vil han skabe raketvækst på fedt til bryster.
Stem Medical vil erstatte brystimplantater med en stamcellebaseret løsning – nye investorer skal sikre europæisk udrulning.
LSX World Congress 2023
Leading investors discuss the global investment landscape and shifts in public and private finance, as well as what they expect 2023 and onwards to hold.
Stamcelleselskab har sikret sig halvdelen af ønsket kapital
Stamcellefirmaet Stemmedicalindledte i sommeren 2022 en pengerunde, der skulle sikre selskabet i alt 15 mio. euro, svarende til næsten 112 mio. kr., og nu er halvdelen af pengene i hus, oplyser Stemmedical til Børsen.
Message from the CEO
I have a passion for succeeding in bringing evidence based stem cell based therapies to patients. I believe we are the first and only company in the world to overcome the three barriers that prevent stem cell based therapies reaching patients. We are now on a mission to develop our stem cell platform with partners and reach patients across the world.